How Elam was paid
$2.9M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Other | Total |
|---|---|---|---|---|---|
| Nevan Charles ElamChief Executive Officer | $610,825 | $451,662 | $1,767,204 | $21,418 | $2,851,109 |
| Brian Roberts, M.D.Chief Medical Officer | $483,361 | $221,988 | $667,202 | $62,177 | $1,434,728 |
| Daron EvansChief Financial Officer | $421,458 | $231,112 | $1,016,452 | $46,639 | $1,715,661 |
| Sunil KarnawatChief Commercial Officer | — | — | — | — | — |
What changed and why
- $2.9M$2,851,109 was CEO Nevan Charles Elam’s total compensation for fiscal 2025.
- $1.8M$1,767,204 of Elam’s compensation consisted of stock awards.
- $1.4M$1,434,728 was Chief Medical Officer Brian Roberts’s total compensation for fiscal 2025.
- $1.7M$1,715,661 was Chief Financial Officer Daron Evans’s total compensation for fiscal 2025.
- 60%60% was Elam’s calendar-year target bonus opportunity.
- 50%Cash bonuses reflected approximately 50% of estimated 2025 calendar-year target bonus amounts.
Other Rezolute proxy statements
- 2026 proxy statement
Nevan Charles Elam paid $5.7M (+100% on the year).
Filed Oct 21, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.